All of the links below pertaining to the 2018 International Evidence Based Guideline for the Diagnosis and Management of PCOS are endorsed by the AE-PCOS Society.
These infographics were created as part of the 2018 International Guideline on PCOS. Please click on each image to learn more:
Fertility and Pregnancy
Download 'ASK PCOS' here.
AskPCOS App is developed by experts, based on the best available evidence and co-designed by women with PCOS. AskPCOS is for women and girls who think they may have PCOS, those who already have a diagnosis, and for those supporting women with PCOS.
AskPCOS has a range of innovative features including: - A self-diagnostic quiz - Easy to understand information on PCOS - A range of info-graphics - Videos by experts - A question prompt list to assist you when talking to health professionals AskPCOS is essential for women wanting the best available information about PCOS.
Watch and listen here.
The terms Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Disease (PCOD) are commonly used interchangeably. We prefer to use the term Polycystic Ovary Syndrome (PCOS) because the signs and symptoms of this condition vary, and not all women with PCOS will necessarily have all the signs and symptoms. “Syndrome” is the favored term because it alludes to the presence of varied signs and symptoms and does not imply a precise cause of the condition, as the exact cause of PCOS has yet to be determined. This definition is in contrast to that of a "disease” where there is typically a specific cause for the condition. PCOS was earlier called “Stein-Leventhal Syndrome” which is a term currently not used.Back to Top
In order for your doctor to make the diagnosis of PCOS, he/she will have to obtain a detailed medical and gynecological history. In addition, your physician will need to perform a physical examination, which includes clinical examination for symptoms of androgen excess, laboratory tests and an ultrasound of the pelvis.
The current criteria for the diagnosis of PCOS include the following items:
1. Signs of excess androgens (male hormones) in the form of excess hair growth or blood tests that show elevated levels of androgens
2. Irregular or absent periods or polycystic ovaries on ultrasound.
There is also the need to confirm the lack of any other conditions that would explain the above signs and symptoms, since problems with other endocrine glands can cause similar symptoms.
No, this is not true. Although it is true that PCOS can cause difficulty getting pregnant, its effects go far beyond fertility. A few good examples of these effects include hirsutism (hair growth), insulin resistance, heart disease risk factors, and even uterine cancer. This list is far from complete, but in reviewing a few examples you may gain some idea of the importance of seeking treatment for PCOS long before you desire pregnancy.
Hirsutism is the excess growth of coarse dark hair in a predominantly male pattern. Women affected by PCOS commonly experience hirsutism due to increased levels of the male hormones called androgens. The longer a women with PCOS goes untreated the more severe her hirsutism will become.
Insulin resistance is a condition common to PCOS in which the tissues of the body become less responsive to the hormone insulin. If left untreated, the body may become so unresponsive to insulin as to develop a type of diabetes. If diagnosed appropriately, there are treatments available which can prevent the progression to diabetes.
Heart disease risk factors are more common in women with PCOS. Women affected by PCOS are frequently overweight, have increased levels of androgens, and may have insulin resistance, elevated cholesterol, and high blood pressure. With proper attention these risk factors can be treated, however, if left untreated they can increase the woman's risk of heart disease.
Women with PCOS can often go great lengths of time without a menstrual period. When this occurs the inside lining of their uterus, called the endometrium, is exposed to the hormone estrogen for long periods of time 'without a break'. This can lead to a condition of disorganized cell growth within the endometrium. If left untreated this disorganized cell growth can develop into cancer of the uterus. With appropriate medical treatment this can be prevented in almost all cases. Having said this, it is very important that we stress that it is not the period itself that prevents endometrial cancer. Rather, it is exposure of the uterine lining to the hormone progesterone - which is commonly lacking in women with PCOS. Appropriate treatment to prevent uterine cancer will include a progesterone-like medication.Back to Top
Glucophage, the brand name for metformin, is a medication that is designed to treat people with type II diabetes. There are many brands of metformin available. Metformin works in two ways. Firstly, it decreases glucose (sugar) production in the liver, and secondly, it increases the sensitivity of body tissues to the hormone insulin. In this way, the body is able to maintain a more normal sugar level with lower insulin levels.
For the woman with PCOS who has insulin resistance, higher insulin levels are required to maintain blood sugar levels. Elevated insulin levels in the blood have negative effects that can lead to diabetes. Metformin can help maintain a lower blood sugar level with less insulin. Hence, there is less insulin available to induce the negative effects of elevated insulin levels. This has been shown to translate into weight loss, lower androgen levels, and even increased ovulation in some women.
Metformin is generally a safe medication, although some side effects may occur. The majority of these side effects are minor and improve with continued use of the medication. The most common side effects are nausea, diarrhea, and stomach upset. This can be improved by taking metformin with meals. Metformin has been associated with one very rare and possibly serious side effect called "lactic acidosis". This condition occurs most commonly in people with kidney problems, and has been seen in approximately 1 in 33,000 people. If you know that you have kidney or liver problems make sure your doctor is aware of this before you begin taking metformin.
Metformin has been taken in pregnancy without an increased risk to the fetus, although long-term information is not yet available. If you do become pregnant while taking metformin, stop the medication and see your physician who will advise you further on any need to take metformin during pregnancy. Available data would suggest that using the medication in early pregnancy should not be expected to cause problems for the baby.Back to Top
At this time there is no cure for PCOS. However, with proper treatment many of the symptoms can be controlled and possibly even eliminated. With appropriate treatment hirsutism, acne, irregular periods, weight gain, and infertility all can be treated. Although there is no cure, all women with PCOS should seek the care of a physician to optimize their health and prevent progression of symptoms and their ill effects.Back to Top
Women with PCOS are commonly bothered by very irregular menstrual periods. Often, women report they would rather have regular and predictable cycles rather than the random episodes of heavy bleeding they are experiencing. On the other hand, we frequently hear women say they prefer not having a period every month, and would rather not be bothered by regular cyclic bleeding. Whatever your preference, this is a personal choice for each woman to make, and your physician can help you obtain your goals.
What is more important than the actual act of bleeding is the abnormal hormone levels that lead to irregular periods in women with PCOS. Women affected by PCOS do not ovulate on a regular basis. As a result, the inside lining of the uterus - called the endometrium - is exposed to the hormone estrogen for great lengths of time without being exposed to the hormone progesterone, which is released after ovulation. It is the cyclic rise and fall in both estrogen and progesterone that causes menstrual bleeding. In the case of PCOS, there can be prolonged lengths of time without the production of progesterone. During this time the endometrium is continuously exposed to estrogen. The result of this prolonged estrogen exposure is the buildup of the endometrium. When the endometrium becomes too thick, heavy and irregular bleeding can occur. Also, when the endometrium is exposed to estrogen for prolonged periods of time, cell changes can occur in which the endometrium becomes abnormal and, if not treated appropriately, can develop into cancer. Progesterone prevents the build-up of the endometrium.
Thus, in order to protect the endometrium from the effects of prolonged estrogen exposure we need to provide progesterone in some way. For most women, this is easily done using the oral contraceptive pill. The pill, when used in this way, can provide several benefits at the same time. First, the pill contains a progesterone-like compound that will protect the endometrium from the cell changes mentioned earlier. Second, the pill will provide women with a regular and predictable menstrual cycle. Third, for women who do not want to become pregnant, the pill provides reliable contraception.
Although the oral contraceptive pill is the most commonly used medication, it is important to understand that it may not be for everyone. Some women cannot tolerate the pill and for these women taking a progesterone-like medication for approximately two weeks each month can protect the endometrium. This will produce a regular and predictable menses. However, it will not provide contraception. For the woman who does not want to experience regular cycles, but needs to have her endometrium protected from the continuous estrogen, there are ways to provide the needed progesterone without causing a monthly period. Obviously, for women who desire pregnancy, oral contraceptive pills are not ideal. For these women, medications are available to induce ovulation. With ovulation there is production of the progesterone that is needed to protect the endometrium.
Overall, it is necessary for women with PCOS to receive some type of hormone therapy to provide progesterone in order to protect their endometrium. The oral contraceptive pill is the most common means of providing this hormone replacement, however, it is not the only option. Your doctor will be able to provide you with the medication that best fits your personal goals.Back to Top
This discoloration may represent a condition called acanthosis. Acanthosis nigricans is a condition in which the skin at specific sites - most commonly the neck, groin region, under the breasts and arms - becomes darker in color and is often said to appear velvety. Acanthosis is an outwardly visible sign of insulin resistance with elevated levels of insulin. The level of insulin resistance determines the severity of acanthosis. Acanthosis can occur in any race. Although acanthosis is a good marker for insulin resistance, not all women with acanthosis will be found to have insulin resistance. The exact mechanism by which insulin resistance causes acanthosis is not known.Back to Top
A diagnosis of PCOS suggests that you are likely to have some difficulty becoming pregnant. However, with help from you doctor, pregnancy should be an option for almost everyone with PCOS. Women with PCOS generally have irregular, infrequent, or even absent ovulation. Without ovulation there is no egg that is available for fertilization. Also, due to the abnormal hormone levels, the endometrium, or inside lining of the uterus, does not develop normally in women with PCOS. Therefore, even if a rare ovulation was to occur and the egg was fertilized, the endometrium may not be properly developed to allow for the attachment and growth of the embryo. This may explain the increased risk of miscarriage in women with PCOS.
Your doctor can provide you with medications that can help you ovulate, in a process called ovulation induction. Common ovulation induction agents include clomiphene citrate (brand names include Serophene, Clomid) and human menotropins or gonadotropins (brand names include Pergonal, Humegon, Repronex, Follistim, Gonal-F). Insulin sensitizers such as metformin can also be used to improve the likelihood of ovulation. If ovulation induction alone is not successful in producing a normal pregnancy, then the use of the assisted reproductive technologies (ART) - such as in vitro fertilization, can be attempted.Back to Top
CARES Foundation, Inc. is a nonprofit patient support and advocacy organization dedicated to serving the needs of the CAH (congenital adrenal hyperplasia) community.
Jean Hailes Foundation in Australia is a not for profit women's health organization providing clinical care education and research in PCOS.
PCOS Challenge, Inc. is the leading 501(c)(3) nonprofit organization advancing the cause for women and girls with Polycystic Ovarian Syndrome, serving 35,000 members.
The PCOSA is a national nonprofit organization operated by women with polycystic ovary syndrome.
RESOLVE is a national infertility association. It is dedicated to providing education, advocacy and support for men and women facing the crisis of infertility.
Path2Parenthood (P2P) is an inclusive organization committed to helping people create their families by providing leading-edge outreach programs and timely educational information. The scope of our work encompasses reproductive health, infertility prevention and treatment, and family-building options including adoption and third party solutions. P2P is a national, not-for-profit 501(c)(3) charitable organization headquartered in New York City.
The Hormone Foundation is an independent, nonprofit organization established by The Endocrine Society. Its mission is to improve quality of life by promoting the prevention, diagnosis, and treatment of human disease in which hormones play a role.
The NCIID is an Internet nonprofit site dedicated to advocacy of the infertile consumer.
|Ricardo Azziz, MD, MPH, MBA
Regents' Professor, Georgia Regents University
|MCG Reproductive Medicine & Infertility Associates||(706) 722-4434
810 Chafee Ave, Augusta, GA 30904, USA
|Fida Bacha, MD||Division of Pediatric Endocrinology and Diabetes, Texas Children's Hospital, Baylor College of Medicine||6701 Fannin Street, 77030 Houston, TX|
|Jean-Patrice Baillargeon, MD PhD
Professor, Universitaire de Sherbrooke
|Centre Hospitalier Universitaire de Sherbrooke||(819) 346-1110 | Ext. 14853
3001, 12e Avenue Nord, Sherbrooke QC J1H 5N4
|M. Tracy Bekx, MD||American Family Children's Hospital, University of Wisconsin, Madison, Wisconsin||(608) 263-9059
H4/414 CSC, 600 Highland Avenue, Madison, Wisconsin 53792, USA
|Ann J Brown, MD, MHS Vice Dean for Faculty||Duke University School of Medicine||(919) 684-4139 Administrative office
(919) 684-5002 Clinical Office
(919) 681-7796 FAX
|Tania S Burgert, MD
Assistant Professor, University of Missouri-Kansas City School of Medicine
|The Children's Mercy Hospital, Kansas City||(816) 960-8803
3101 Broadway Boulevard, Kansas City, MO 64111
|Donna R Chizen, MD
Associate Professor, University of Saskatchewan
|Royal University Hospital||(306) 844-1063
103 Hospital Drive, Saskatoon, SK S7N 0W8
|Ellen L. Connor, MD
Professor, University of Wisconsin
|American Family Children's Hospital||(608) 263-6420
600 Highland Avenue, Madison, WI 53792
|Anuja Dokras, MD PhD
Professor, University of Pennsylvania
|Penn Fertility Care
Penn PCOS Center
8th floor, 3701 Market Street, Philadelphia, PA 19104
|David A. Ehrmann, MD||The University of Chicago Center for Polycystic Ovary Syndrome||(773) 702-4295
5841 S. Maryland Ave., MC1027, Chicago, Illinois space 60637, USA
|Felice L. Gersh, MD||Integrative Medical Group of Irvine||(949) 753-7475
4968 Booth Circle, #101, Irvine, CA 92604, USA
|Jennifer Glueck, MD
||Reproductive and Endocrine Health||(847) 786-0048
600 Central Avenue, Suite 315, Highland Park, IL 60091, USA
|Mark O. Goodarzi, MD, PhD
Director, Division of Endocrinology, Diabetes and Metabolism
Professor of Medicine, Cedars-Sinai Medical Center
|Cedars-Sinai Medical Center||(310) 423-3870
Steven Spielberg Building, 8723 Alden Drive, Suite 250, Los Angeles, CA 90048
|Neil Goodman, MD FACE
||Reproductive Health Physiciansfirstname.lastname@example.org
9150 SW 87th Ave, Suite 210, Miami, FL 33176
|Angela Grassi, MS RD LDN
||The PCOS Nutrition Centeremail@example.com
14 S. Bryn Mawr Avenue, Suite 204, Bryn Mawr, PA 19010
|Robert P. Kauffman, MD
Professor and Regional Chairman
Director, Reproductive Medicine and Infertility
|Texas Tech Physicians
Department of Obstetrics and Gynecology of Texas Tech University Health Sciences Center School of Medicine
TTUHSC, 1400 S. Coulter Drive, Amarillo, Texas 79106, USA
|Rashmi Kudesia, MD, MSc, FACOG Assistant Professor, Division of Reproductive Endocrinology & Infertility||Reproductive Medicine Associates of New York, Icahn School of Medicine at Mount Sinai||(718) 532-8700
26 Court Street, Suite 2710, Brooklyn NY 11242, USA
|Bruce A. Lessey, MD, PhD||Fertility Center of the Carolinas||(864) 455-1600
890 W. Faris Road, Suite 470, Greenville, SC 29605, USA
101 Halton Village Circle, Greenville, SC 29607, USA
333 S. Pine Street, Spartanburg, SC 29302, USA
2000 E. Greenville Street, Suite 4600, Anderson, SC 29621, USA
|Shahab Minassian, MD
||RHPN IVF-Fertility||(610) 374-2214
Suite 245, 301 South Seventh Avenue, West Reading, PA 19611
|Sasha Ottey Executive Director||PCOS Challenge||(404) 855-7244
931 Monroe Dr. NE, Suite A-470, Atlanta GA 30308, USA
|Gregory S Pokrywka MD, FACP, FNLA, NCMP Director||Baltimore Lipid Center||(410) 337-0720
7801 York Rd Suite # 300 , Baltimore MD 21204
|Nazia Raja-Khan, MD||Penn State Hershey Medical Center
Division of Endocrinology, Diabetes and Metabolism
500 University Drive, Mailcode H044, Hershey, Pennsylvania 17033, USA
|Batul Valika, MD
||Aurora Health Center||(610) 374-2214
Suite 245, 301 South Seventh Avenue, West Reading, PA 19611
|Robert A Wild, MD PhD
Professor, University of Oklahoma
|OU Medicine, Women's Services||(405) 271-5239
825 NE 10th St, Oklahoma City, OK 73104
|Selma Feldman Witchel, MD||Children's Hospital of Pittsburgh of UPMC Pediatric Endocrinology||(412) 692-7618
4401 Penn Avenue, Pittsburgh, PA 15224, USA
|Leonardo Jose Gonzalez Garcia
Specialist in Reproductive Endocrinology, Infertility and Gyn Laparoscopic Surgery
|Centro de Fertilidad y Endocrinologia Reproductiva||
Cra 23 # 65 A 41 Edificio Parque Medico, Manizales, Caldas, Colombia (South America)
|Alexandre Hohl, MD PhD
Professor, Universidade Federal de Santa Catarina
|Clinica Medica Dr. Hohl||+55 48 30246848
Avenida Prefeito Osmar Cunha, 416 / 605 Florianopolis - SC, Brazil 88015-100
|Maria Ines Martinez
Ginecologia Pediatrica y de Adolescentes
|Pediatric and Adolescent Gynecology(PAG)||+598 2 2035205
+598 9 4386035
Espinillo1386, Montevideo, Uruguay
|Konstantinos Tserotas, MD, FACOG||Centro Integral de Atencion Femenina||(507) 263-1542
Consultorios Medicos Royal Center, Oficina 306 A, Calle 53 Marbella, Panama City, Republic of Panama
|Jaime Urdinola MD
Specialist in Gynecological Endocrinology
|Menopausia Asociacion Medica de los Andes||+57 1215-2300 (office)
+57 1215-0849 (appointment only)
AK 9 116 20 CS 326, Asociacion Medica de los Andes, Bogota 110111, Colombia
|Salvatore Benvenga, MD
Professor of Medicine, University of Messina Director, Master Program on Childohood, Adolescent and Women's Endocrine Health Chief, Interdept. Program on Clinical & Molecular Endocrinology, and Women's Endocrine Health
|A.O.U. Policlinico Universitario G. Martin
Clinic of Endocrinology, Diabetes and Metabolic Diseases
Faculty of Medicine, University of Messina
+39 090 221 7107
firstname.lastname@example.org Padiglione H, 4 piano, 98125 Messina, Italy
|Enrico Carmina, MD
Professor of Reproductive Endocrinology
|University of Palermo, Palermo, Italy||+39 091 332377
Via Villareale 40, Palermo, Italy
|Héctor F. Escobar-Morreale, MD, PhD
Head, Department of Endocrinology & Nutrition Professor of Medicine & Endocrinology Hospital Universitario Ramón y Cajal & University of Alcalá Director, Diabetes, Obesity and Human Reproduction Research Group Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas CIBERDEM Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS
|Universidad de Alcalá, Madrid, Spain||+34 91 336 9029
Carretera de Colmenar Km 9'1, E-28034 Madrid, Spain
|Mohd Ashraf Ganie
||All India Institute of Medical Sciences, New Delhi||
+91 11 26593968
Department of Endocrinology and Metabolism, All India Institute of Medical Sciences New Delhi,India
|Lourdes Ibanez, MD PhD
Professor, University of Barcelona
|Hospital Sant Joan de Deu
University of Barcelona
|+34 932 53 21 00
08950 Esplugues de Llobregat, Barcelona, Spain
|Zdravko Kamenov||Clinic of Endocrinology, Alexandrovska University hospital, Medical University-Sofia||
1, G.Sofiiski Str., Sofia, Bulgaria
|Sujata Kar, MBBS, MD, DNB
Consultant Obs & Gyn
|Kar Clinic and Hospital||
KCHPL, Bhubaneswar, Odisha, India
||The Philip Kingsley Trichological Clinic||
54 Green Street, London W1K 6RU
|Instituto Catalan de Endocrinologia||+34 934183304 (office)
+34 616461121 (mobil)
Paseo Bonanova 69, Barcelona 08017, Spain
|Djuro Macut MD, PhD
Associated Professor, University of Belgrade
|Clinic of Endocrinology, Diabetes and Metabolic Diseases
Faculty of Medicine, University of Belgrade
Dr Subotica 13, 11000 Belgrade, Serbia
Assistant Professor, Specialist in Gynecology and Obstetrics and reproductive endocrinology
|University Hospital of Oulu, Oulu, Finlandemail@example.com
Dept Obst/Gyn, PL 23, FIN 90029 OYS, Finland
|Muna Tahlak, MD
Dubai, United Arab Emirates
||FertilitySA and the Royal Adelaide Hospital||+61 8 8100 2900 (FertilitySA)
+61 8 8222 5587 (RAH)
Royal Adelaide Hospital Womens' Health Service, North Terrace, Adelaide SA5000